# Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

> **NCT01802593** · PHASE4 · TERMINATED · sponsor: **Prof. Arie Levine** · enrollment: 20 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** AZATHIOPRINE or METHOTREXATE
- **DRUG:** AZATHIOPRINE or METHOTREXATE

## Key facts

- **NCT ID:** NCT01802593
- **Lead sponsor:** Prof. Arie Levine
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** lack of budget and failure to reach milestones
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802593, "Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01802593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*